PERRY A KARSEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PERRY A KARSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERRY A KARSEN. PERRY A KARSEN is a see remarks in CELGENE CORP /DE/ ($CELG) and a Senior Vice President in HUMAN GENOME SCIENCES INC ($HGSI) and a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Director in OncoMed Pharmaceuticals Inc ($OMED) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Voyager Therapeutics, Inc. ($VYGR) and a Director in Jounce Therapeutics, Inc. ($JNCE) and a Director in Intellia Therapeutics, Inc. ($NTLA).
Address: 9410 KEY WEST AVENUE ROCKVILLE 20850 MD
Companies in which PERRY A KARSEN is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERRY A KARSEN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2015
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELGENE CORP /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERRY A KARSEN: see remarks
Holdings: 66,432 shares
Current Value: $7,723,384
Latest Transaction: Dec 18 2015
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HUMAN GENOME SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERRY A KARSEN: Senior Vice President
Holdings: 0 shares
Latest Transaction: Sep 15 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PERRY A KARSEN: Director
Holdings: 36,764 shares
Current Value: $488,961
Latest Transaction: Dec 18 2020
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERRY A KARSEN: Director
Holdings: 5,000 shares
Current Value: $86,500
Latest Transaction: Jun 29 2020
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PERRY A KARSEN: Director
Holdings: 37,528 shares
Current Value: $19,515
Latest Transaction: Jul 21 2015
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoMed Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERRY A KARSEN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2019
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Voyager Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERRY A KARSEN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 17 2019
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PERRY A KARSEN
Sentiment: All, AGIO, CELG, HGSI, NTLA, JNCE, NAVB, OMED, VYGR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 15.78 | 19,000 | 299,820 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 25.98 | 19,000 | 493,620 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 14.35 | 19,000 | 272,650 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 18.00 | 31,764 | 571,752 | 0 | |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 54.33 | 21,336 | 1,159,185 | 5,000 | 26.3 K to 5 K (-81.01 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 53.69 | 45,450 | 2,440,211 | 26,336 | 71.8 K to 26.3 K (-63.31 %) |
| Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Sell | S | 52.52 | 21,978 | 1,154,285 | 71,786 | 93.8 K to 71.8 K (-23.44 %) |